We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-0.69%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$67.5B
AUM Growth
+$10.9B
(+19%)
Cap. Flow
+$12.7B
Cap. Flow
% of AUM
18.75%
Top 10 Holdings %
Top 10 Hldgs %
49.27%
Holding
2,060
New
26
Increased
289
Reduced
1,527
Closed
195
Top Buys
| 1 |
IQMM
ProShares GENIUS Money Market ETF
IQMM
|
+$19.7B |
| 2 |
Walmart Inc
WMT
|
+$729M |
| 3 |
Kimberly-Clark
KMB
|
+$33.1M |
| 4 |
Erie Indemnity
ERIE
|
+$26.7M |
| 5 |
Becton Dickinson
BDX
|
+$26.1M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$799M |
| 2 |
Apple
AAPL
|
+$563M |
| 3 |
Microsoft
MSFT
|
+$445M |
| 4 |
Amazon
AMZN
|
+$321M |
| 5 |
Broadcom
AVGO
|
+$274M |
Sector Composition
| 1 | Technology | 23.92% |
| 2 | Consumer Staples | 7.59% |
| 3 | Consumer Discretionary | 6.94% |
| 4 | Communication Services | 6.66% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Vertex Pharmaceuticals
VRTX
$123B
| $167M | 0.25% |
373,532
-83,514
| -18% | -$38.9M |
|
77
West Pharmaceutical
WST
$25.3B
| $165M | 0.25% |
660,084
+73,237
| +12% | +$18.2M |
|
|
78
Kimberly-Clark
KMB
$36B
| $165M | 0.24% |
1,708,881
+323,159
| +23% | +$33.1M |
|
|
79
Becton Dickinson
BDX
$43.6B
| $164M | 0.24% |
1,044,249
+142,441
| +16% | +$26.1M |
|
80
Nordson
NDSN
$16.1B
| $163M | 0.24% |
613,486
-73,438
| -11% | -$20.2M |
|
81
Nucor
NUE
$53.9B
| $163M | 0.24% |
961,260
-247,227
| -20% | -$43.1M |
|
82
Lowe's Companies
LOW
$117B
| $162M | 0.24% |
685,431
-75,916
| -10% | -$19.8M |
|
83
PPG Industries
PPG
$26.2B
| $161M | 0.24% |
1,510,911
-89,315
| -6% | -$10.1M |
|
84
Medtronic
MDT
$106B
| $161M | 0.24% |
1,859,349
-52,382
| -3% | -$5.02M |
|
85
Amcor
AMCR
$20.3B
| $159M | 0.24% |
4,001,955
+10,253
| +0.3% | +$453K |
|
86
S&P Global
SPGI
$133B
| $159M | 0.24% |
373,804
-21,775
| -6% | -$10.1M |
|
87
Essex Property Trust
ESS
$18.8B
| $159M | 0.24% |
656,067
+36,822
| +6% | +$9.29M |
|
88
Sysco
SYY
$39.1B
| $158M | 0.23% |
2,220,986
+115,982
| +6% | +$9.59M |
|
89
Brown-Forman Class B
BF.B
$11.7B
| $158M | 0.23% |
5,985,443
+309,112
| +5% | +$8.3M |
|
90
J.M. Smucker
SJM
$12B
| $158M | 0.23% |
1,635,476
+100,898
| +7% | +$10.6M |
|
91
Clorox
CLX
$11.6B
| $157M | 0.23% |
1,515,910
+150,102
| +11% | +$17M |
|
92
C.H. Robinson
CHRW
$24.6B
| $156M | 0.23% |
939,060
-329,155
| -26% | -$58.9M |
|
93
Emerson Electric
EMR
$78.2B
| $156M | 0.23% |
1,187,923
-133,989
| -10% | -$19.3M |
|
94
Franklin Resources
BEN
$17B
| $155M | 0.23% |
6,556,326
-526,842
| -7% | -$13.6M |
|
95
Hormel Foods
HRL
$14B
| $155M | 0.23% |
6,822,917
+204,162
| +3% | +$4.88M |
|
96
A.O. Smith
AOS
$8.11B
| $152M | 0.23% |
2,309,570
-35,061
| -1% | -$2.53M |
|
97
Goldman Sachs
GS
$314B
| $151M | 0.22% |
178,449
-2,286
| -1% | -$2.04M |
|
|
98
Erie Indemnity
ERIE
$11.9B
| $150M | 0.22% |
597,974
+99,508
| +20% | +$26.7M |
|
99
Expeditors International
EXPD
$23.9B
| $149M | 0.22% |
1,037,248
-323,659
| -24% | -$49.2M |
|
100
ASML
ASML
$671B
| $148M | 0.22% |
112,009
-24,286
| -18% | -$33.3M |
|
Similar funds
ProShare Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, ProShare Advisors held 2,060 positions worth $67.5B, up 19% from $56.7B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
ProShare Advisors deployed $12.7B of net new capital in Q1 2026, opening 26 new positions and adding to 289 existing holdings. Its largest new stake was ProShares GENIUS Money Market ETF: 197,028,347 shares worth $19.7B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 37% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $799M trimmed.
- ProShare Advisors's largest Q1 2026 buy was ProShares GENIUS Money Market ETF: 197,028,347 shares worth $19.7B.
- ProShare Advisors added most to Walmart Inc in Q1 2026, an estimated $729M increase.
- ProShare Advisors's biggest Q1 2026 reduction was NVIDIA, cutting an estimated $799M.
- ProShare Advisors fully exited AstraZeneca in Q1 2026, selling an estimated $85.7M.
- ProShare Advisors's ten largest holdings make up 49% of its $67.5B portfolio in Q1 2026.
- ProShare Advisors opened 26 new positions and closed 195 in Q1 2026.
- ProShare Advisors's portfolio value rose 19% quarter-over-quarter to $67.5B.
Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.